CD96 and breast cancer: CD155 knockout promoted chemosensitivity to docetaxel in BCSCs expressing high levels of CD96 (Figure S6C, Supporting Information) but had little effect on BC cells with low CD96 expression (Figure S6D, Supporting Information).